These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 33280083

  • 1. Pyronaridine: An update of its pharmacological activities and mechanisms of action.
    Bailly C.
    Biopolymers; 2021 Apr; 112(4):e23398. PubMed ID: 33280083
    [Abstract] [Full Text] [Related]

  • 2. In Vitro Sensitivity of Pyronaridine in Thai Isolates of Plasmodium falciparum.
    Mahotorn K, Tan-Ariya P, Thita T, Ruang-Areerate T, Sittichot N, Suwandittakul N, Mungthin M.
    Am J Trop Med Hyg; 2018 Jan; 98(1):51-56. PubMed ID: 29141758
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
    Kurth F, Pongratz P, Bélard S, Mordmüller B, Kremsner PG, Ramharter M.
    Malar J; 2009 Apr 23; 8():79. PubMed ID: 19389221
    [Abstract] [Full Text] [Related]

  • 4. Review of pyronaridine anti-malarial properties and product characteristics.
    Croft SL, Duparc S, Arbe-Barnes SJ, Craft JC, Shin CS, Fleckenstein L, Borghini-Fuhrer I, Rim HJ.
    Malar J; 2012 Aug 09; 11():270. PubMed ID: 22877082
    [Abstract] [Full Text] [Related]

  • 5. Comparison of hematin-targeting properties of pynacrine, an acridine analog of the benzonaphthyridine antimalarial pyronaridine.
    Sereekhajornjaru N, Somboon C, Rattanajak R, Denny WA, Wilairat P, Auparakkitanon S.
    Acta Trop; 2014 Dec 09; 140():181-3. PubMed ID: 25220507
    [Abstract] [Full Text] [Related]

  • 6. Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro.
    Chavalitshewinkoon-Petmitr P, Pongvilairat G, Auparakkitanon S, Wilairat P.
    Parasitol Int; 2000 Feb 09; 48(4):275-80. PubMed ID: 10725690
    [Abstract] [Full Text] [Related]

  • 7. Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.
    Rottmann M, Jonat B, Gumpp C, Dhingra SK, Giddins MJ, Yin X, Badolo L, Greco B, Fidock DA, Oeuvray C, Spangenberg T.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32041711
    [Abstract] [Full Text] [Related]

  • 8. Pyronaridine: a review of its clinical pharmacology in the treatment of malaria.
    Chu WY, Dorlo TPC.
    J Antimicrob Chemother; 2023 Oct 03; 78(10):2406-2418. PubMed ID: 37638690
    [Abstract] [Full Text] [Related]

  • 9. Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite.
    Kannan D, Yadav N, Ahmad S, Namdev P, Bhattacharjee S, Lochab B, Singh S.
    EBioMedicine; 2019 Jul 03; 45():261-277. PubMed ID: 31255656
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine-artesunate Study Team.
    Lancet; 2010 Apr 24; 375(9724):1457-67. PubMed ID: 20417857
    [Abstract] [Full Text] [Related]

  • 11. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
    Vivas L, Rattray L, Stewart L, Bongard E, Robinson BL, Peters W, Croft SL.
    Acta Trop; 2008 Mar 24; 105(3):222-8. PubMed ID: 18279817
    [Abstract] [Full Text] [Related]

  • 12. Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria.
    Ringwald P, Meche FS, Basco LK.
    Am J Trop Med Hyg; 1999 Sep 24; 61(3):446-8. PubMed ID: 10497988
    [Abstract] [Full Text] [Related]

  • 13. The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus.
    Kawai S, Kano S, Chang C, Suzuki M.
    Am J Trop Med Hyg; 1996 Aug 24; 55(2):223-9. PubMed ID: 8780465
    [Abstract] [Full Text] [Related]

  • 14. Targeting of hematin by the antimalarial pyronaridine.
    Auparakkitanon S, Chapoomram S, Kuaha K, Chirachariyavej T, Wilairat P.
    Antimicrob Agents Chemother; 2006 Jun 24; 50(6):2197-200. PubMed ID: 16723583
    [Abstract] [Full Text] [Related]

  • 15. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U.
    Life Sci; 2007 Feb 06; 80(9):813-28. PubMed ID: 17157328
    [Abstract] [Full Text] [Related]

  • 16. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM, Sawa P, Makio N, Omweri G, Osoti V, Okach S, Choy F, Schallig HDFH, Mens P.
    Malar J; 2018 May 15; 17(1):199. PubMed ID: 29764419
    [Abstract] [Full Text] [Related]

  • 17. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM).
    Lancet; 2018 Apr 07; 391(10128):1378-1390. PubMed ID: 29606364
    [Abstract] [Full Text] [Related]

  • 18. Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum.
    Birrell GW, Challis MP, De Paoli A, Anderson D, Devine SM, Heffernan GD, Jacobus DP, Edstein MD, Siddiqui G, Creek DJ.
    Mol Cell Proteomics; 2020 Feb 07; 19(2):308-325. PubMed ID: 31836637
    [Abstract] [Full Text] [Related]

  • 19. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa.
    Ringwald P, Bickii J, Basco L.
    Lancet; 1996 Jan 06; 347(8993):24-8. PubMed ID: 8531545
    [Abstract] [Full Text] [Related]

  • 20. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
    Rueangweerayut R, Phyo AP, Uthaisin C, Poravuth Y, Binh TQ, Tinto H, Pénali LK, Valecha N, Tien NT, Abdulla S, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine–Artesunate Study Team.
    N Engl J Med; 2012 Apr 05; 366(14):1298-309. PubMed ID: 22475593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.